Literature DB >> 20307667

Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.

James G Greene1, Raymond Dingledine, J Timothy Greenamyre.   

Abstract

Dopamine (DA) neurons in the substantia nigra (SNDA neurons) are among the most severely affected in Parkinson's disease (PD). Mitochondrial complex I inhibition by rotenone or MPTP can induce SNDA neurodegeneration and recapitulate motor disability in rodents. We performed a transcriptional analysis of the midbrain response to complex I inhibition focused on selected metabolic transcripts using quantitative real-time RT-PCR in conjunction with laser-capture microdissection (LCM) of immunofluorescently targeted SNDA and ventral tegmental area (VTA) DA neurons. There were DA neuron-selective alterations in metabolic transcripts in response to generalized complex I inhibition dependent on the behavioral response of the animal, and vulnerable SNDA neurons were more dynamic in their metabolic transcriptional response than less vulnerable VTADA neurons. The metabolic transcriptional response of DA neurons may contribute significantly to the ultimate toxicity associated with mitochondrial inhibition, and better understanding of this response may provide insight into potential targets for neuroprotection in PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307667      PMCID: PMC2872119          DOI: 10.1016/j.nbd.2010.03.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  39 in total

1.  Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.

Authors:  Peter Teismann; Kim Tieu; Dong-Kug Choi; Du-Chu Wu; Ali Naini; Stéphane Hunot; Miquel Vila; Vernice Jackson-Lewis; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

2.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.

Authors:  Sheila M Fleming; Chunni Zhu; Pierre-Olivier Fernagut; Arpesh Mehta; Cheryl D DiCarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

3.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

4.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

Review 5.  Animal models of PD: pieces of the same puzzle?

Authors:  Ted Dawson; Allen Mandir; Michael Lee
Journal:  Neuron       Date:  2002-07-18       Impact factor: 17.173

6.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  W J Nicklas; I Vyas; R E Heikkila
Journal:  Life Sci       Date:  1985-07-01       Impact factor: 5.037

7.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

Authors:  J S Schneider; A Yuwiler; C H Markham
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

Authors:  Todd B Sherer; Jin Ho Kim; Ranjita Betarbet; J Timothy Greenamyre
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  10 in total

1.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.

Authors:  Debashis Dutta; Nilufar Ali; Emili Banerjee; Raghavendra Singh; Amit Naskar; Ramesh Kumar Paidi; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

Review 2.  Current status and future directions of gene expression profiling in Parkinson's disease.

Authors:  James G Greene
Journal:  Neurobiol Dis       Date:  2010-11-05       Impact factor: 5.996

3.  Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in rats.

Authors:  Qunhua Bai; Junlin He; Yong Tang; Shibo Wang; Jingfu Qiu; Yang Wang; Chao Yu
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

Review 4.  Mouse models of Parkinson's disease associated with mitochondrial dysfunction.

Authors:  Alicia M Pickrell; Milena Pinto; Carlos T Moraes
Journal:  Mol Cell Neurosci       Date:  2012-08-11       Impact factor: 4.314

5.  Region-specific expression of mitochondrial complex I genes during murine brain development.

Authors:  Stefanie Wirtz; Markus Schuelke
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

Review 6.  Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Authors:  Lars Brichta; Paul Greengard
Journal:  Front Neuroanat       Date:  2014-12-15       Impact factor: 3.856

Review 7.  Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.

Authors:  Giorgio Rizzi; Kelly R Tan
Journal:  Front Neural Circuits       Date:  2017-12-22       Impact factor: 3.492

8.  Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys.

Authors:  Laura Campello; Julián Esteve-Rudd; Roque Bru-Martínez; María Trinidad Herrero; Emiliano Fernández-Villalba; Nicolás Cuenca; José Martín-Nieto
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

9.  Identification of neurodegenerative factors using translatome-regulatory network analysis.

Authors:  Lars Brichta; William Shin; Vernice Jackson-Lewis; Javier Blesa; Ee-Lynn Yap; Zachary Walker; Jack Zhang; Jean-Pierre Roussarie; Mariano J Alvarez; Andrea Califano; Serge Przedborski; Paul Greengard
Journal:  Nat Neurosci       Date:  2015-07-27       Impact factor: 24.884

10.  Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity.

Authors:  Di-Sheng Lu; Ce Chen; Ya-Xin Zheng; Dai-Di Li; Guo-Qing Wang; Jie Liu; Jingshan Shi; Feng Zhang
Journal:  Front Mol Neurosci       Date:  2018-05-16       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.